FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2896474842> ?p ?o ?g. }

• W2896474842 endingPage "1606" @default.
• W2896474842 startingPage "1595" @default.
• W2896474842 abstract "Peripheral arterial disease (PAD) is a global health issue associated with impaired functional capacity and elevated risk of major adverse cardiovascular events (MACEs). With changing risk factor profiles and an aging population, the burden of disease is expected to increase. This review considers evidence for the noninvasive management of PAD and makes clinical recommendations accordingly.A comprehensive literature review was performed to examine the evidence for smoking cessation, exercise therapy, antiplatelet therapy, anticoagulant therapy, antihypertensive therapy, lipid-lowering therapy, and glycemic control in diabetes for patients with PAD.Nicotine replacement, bupropion, and varenicline are safe and more effective than placebo in achieving smoking abstinence. Wherever it is practical and available, supervised exercise therapy is ideal treatment for intermittent claudication. Alternatively, step-monitored exercise can increase walking performance and the participant's compliance with less staff supervision. Clopidogrel is preferable to aspirin alone for all patients. However, small studies support the use of dual antiplatelet therapy after revascularization to improve limb outcomes. More recently, the addition of low-dose rivaroxaban to aspirin alone was proven to be more effective in reducing MACEs without a significant increase in major bleeding. However, the exact role of direct oral anticoagulant therapy in the management of PAD is still being understood. Evidence is emerging for more intensive blood pressure and lipid-lowering therapy than traditional targets. Whereas research in PAD is limited, there is clinical scope for an individualized approach to these risk factors. The management of diabetes remains challenging as glycemic control has not been demonstrated to improve macrovascular outcomes. Any potential impact of glycemic control on microvascular disease needs to be weighed against the risks of hypoglycemia. Sodium-glucose cotransporter 2 inhibitors appear to reduce MACEs, although caution is advised, given the increased incidence of lower limb amputation in clinical trials of canagliflozin.Medical and lifestyle management of PAD should aim to improve functional outcomes and to reduce MACEs. Smoking cessation counseling or pharmacotherapy is recommended, although new strategies are needed. Whereas supervised exercise therapy is ideal, there can be barriers to clinical implementation. Other initiatives are being used as an alternative to walking-based supervised exercise therapy. More studies are required to investigate the role of intensive glycemic, blood pressure, and dyslipidemia control in patients with PAD. Overall, a multifactorial approach is recommended to alter the natural history of this condition." @default.
• W2896474842 created "2018-10-26" @default.
• W2896474842 creator A5033273464 @default.
• W2896474842 creator A5042459983 @default.
• W2896474842 creator A5055849986 @default.
• W2896474842 creator A5076214797 @default.
• W2896474842 date "2018-11-01" @default.
• W2896474842 modified "2023-10-12" @default.
• W2896474842 title "Medical and lifestyle management of peripheral arterial disease" @default.
• W2896474842 cites W1485191699 @default.
• W2896474842 cites W1586908370 @default.
• W2896474842 cites W188696429 @default.
• W2896474842 cites W1983269691 @default.
• W2896474842 cites W1996046277 @default.
• W2896474842 cites W2026611219 @default.
• W2896474842 cites W2029008879 @default.
• W2896474842 cites W2033924621 @default.
• W2896474842 cites W2037500444 @default.
• W2896474842 cites W2039186400 @default.
• W2896474842 cites W2043226067 @default.
• W2896474842 cites W2053236269 @default.
• W2896474842 cites W2055552853 @default.
• W2896474842 cites W2075347392 @default.
• W2896474842 cites W2078349288 @default.
• W2896474842 cites W2079595856 @default.
• W2896474842 cites W2087709237 @default.
• W2896474842 cites W2090405682 @default.
• W2896474842 cites W2093915967 @default.
• W2896474842 cites W2101540656 @default.
• W2896474842 cites W2109535127 @default.
• W2896474842 cites W2111088850 @default.
• W2896474842 cites W2117677020 @default.
• W2896474842 cites W2118797814 @default.
• W2896474842 cites W2122891093 @default.
• W2896474842 cites W2125588985 @default.
• W2896474842 cites W2136145230 @default.
• W2896474842 cites W2139176490 @default.
• W2896474842 cites W2140501627 @default.
• W2896474842 cites W2141051547 @default.
• W2896474842 cites W2144663588 @default.
• W2896474842 cites W2144985796 @default.
• W2896474842 cites W2144995242 @default.
• W2896474842 cites W2147663252 @default.
• W2896474842 cites W2148809123 @default.
• W2896474842 cites W2149971684 @default.
• W2896474842 cites W2152798629 @default.
• W2896474842 cites W2156121263 @default.
• W2896474842 cites W2160694670 @default.
• W2896474842 cites W2164089346 @default.
• W2896474842 cites W2167938434 @default.
• W2896474842 cites W2190398275 @default.
• W2896474842 cites W2342634071 @default.
• W2896474842 cites W2529890737 @default.
• W2896474842 cites W2556414715 @default.
• W2896474842 cites W2586156710 @default.
• W2896474842 cites W2597545061 @default.
• W2896474842 cites W2626446274 @default.
• W2896474842 cites W2751210700 @default.
• W2896474842 cites W2768588165 @default.
• W2896474842 cites W2770821084 @default.
• W2896474842 cites W2908737464 @default.
• W2896474842 cites W311320695 @default.
• W2896474842 cites W3150595609 @default.
• W2896474842 cites W4229536675 @default.
• W2896474842 cites W4236878386 @default.
• W2896474842 cites W4243656112 @default.
• W2896474842 cites W4248820097 @default.
• W2896474842 cites W4253437654 @default.
• W2896474842 cites W4289886312 @default.
• W2896474842 doi "https://doi.org/10.1016/j.jvs.2018.07.027" @default.
• W2896474842 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30360849" @default.
• W2896474842 hasPublicationYear "2018" @default.
• W2896474842 type Work @default.
• W2896474842 sameAs 2896474842 @default.
• W2896474842 citedByCount "36" @default.
• W2896474842 countsByYear W28964748422019 @default.
• W2896474842 countsByYear W28964748422020 @default.
• W2896474842 countsByYear W28964748422021 @default.
• W2896474842 countsByYear W28964748422022 @default.
• W2896474842 countsByYear W28964748422023 @default.
• W2896474842 crossrefType "journal-article" @default.
• W2896474842 hasAuthorship W2896474842A5033273464 @default.
• W2896474842 hasAuthorship W2896474842A5042459983 @default.
• W2896474842 hasAuthorship W2896474842A5055849986 @default.
• W2896474842 hasAuthorship W2896474842A5076214797 @default.
• W2896474842 hasBestOaLocation W28964748421 @default.
• W2896474842 hasConcept C126322002 @default.
• W2896474842 hasConcept C134018914 @default.
• W2896474842 hasConcept C142724271 @default.
• W2896474842 hasConcept C177713679 @default.
• W2896474842 hasConcept C1862650 @default.
• W2896474842 hasConcept C2777015399 @default.
• W2896474842 hasConcept C2777466421 @default.
• W2896474842 hasConcept C2777628954 @default.
• W2896474842 hasConcept C2777843972 @default.
• W2896474842 hasConcept C2777849778 @default.
• W2896474842 hasConcept C2778963770 @default.
• W2896474842 hasConcept C2779306644 @default.

• next